Fitzpatrick's Dermatology in General Medicine
Chapter 135. Xanthomatoses and Lipoprotein Disorders
如果要儘快掌握本章重點,不妨看一下筆者仿照Surgical Recall寫的Dermatological Recall。
- 建議可以先遮住右邊,想一下答案大概是什麼。
- (5)表示答案有五項。(訣)表示有筆者自編的口訣。
- 建議可以先遮住右邊,想一下答案大概是什麼。
- (5)表示答案有五項。(訣)表示有筆者自編的口訣。
鄭煜彬
Xanthomatoses and Lipoprotein Disorders: introduction
| |
|
Chlesterol & triglycerides in foamy macrophages
|
|
Skin, tendons, tonsillar(Tangier dz)
|
|
|
|
Eruptive, tubo-eruptive or tuberous, tendinous, or planar.
|
|
Foam cells: Mφcontain lipid.
Eruptive: foam cells+ lymphoid cells, histiocytes, neutrophils, and free lipid in the dermis.
Tuberous/ Tendonous: foam cells+ cholesterol clefts(doubly refractile)
Xanthelasmata: superficial location/eyelids(striated muscle, vellus hair, and/or a thinned epidermis).
|
Lipid and Lipoprotein Metabolism
| |
|
HMG-CoA reductase
|
|
1:4
|
|
Eggs, butter, whole milk, and animal fats as found in meat
|
|
Plant sterols (β-sitosterol and campesterol)
|
|
Bile acids—cholic acid & chenodeoxycholic acid
Steroid hormones: estrogen, testosterone, & cortisol
|
|
cerebrotendinous xanthomatosis(CTX)
|
|
小腸→Chylomicrons→血管→chylomicron remnant→肝→VLDL→血管→VLDL remnant(IDL) →肝→LDL→肝/adipocyte
Mn: C Cr V Vr L(語法:去過血管變~remnant,去過肝變~LDL)
|
|
triglycerides
|
|
Chylomicrons & HDL
|
|
Cholesterol,β-sitosterol and campesterol
|
|
Phytosterolemia(β-sitosterol),會造成tendinous xanthomas.
|
|
A, B48, CII, E。CII
|
|
B48, E。E
|
|
B100, CII, E。CII
|
|
B100, E。B100
|
|
B100
|
|
apoA-I & apoA-II
|
|
Eruptive(severe hypertriglyceridemia)
|
|
tubo-eruptive xanthomas (combined hyperlipidemia)
|
|
tubo-eruptive xanthomas
|
|
tendinous xanthomas(familial hypercholesterolemia)
|
|
tendinous xanthomas
|
|
Familial hypercholesterolemia(IIa)
Familial Lipoprotein (a) Excess(tendinous or tubo-eruptive)
Familial Combined Hyperlipidemia(tendinous or tubo-eruptive)IIb
Familial Dyslipidemia(tubo-eruptive)III
Familial Hypoalphalipoproteinemia(tubo-eruptive)IV
Tangier Disease(yellow/orange hyperplastic tonsils)
|
| 大多不會 |
|
Familial Hypercholesterolemia(tendinous)IIa
Phytosterolemia(tendinous)
Cerebrotendinous Xanthomatosis(tendinous)
Dysbetalipoproteinemia(tubo-eruptive)III
Marked HDL Deficiency(tubo-eruptive)
|
|
Subcutaneous nodules in fascia, ligaments, extensor tendons of hands, knees, elbows, and Achilles tendons
|
|
Sterols: cholesterol,
|
|
Familial hypercholesterolemia (FH, LDL>300mg/dL), phytosterolemia (plant sterols: β-sitosterol and campesterol), or cerebrotendinous xanthomatosis (cholestanol).
|
| |
|
Homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia, or defective apoliprotein-B100
|
|
Tendinous or tuberous xanthomas.
|
|
Arcus senilis, tendinous xanthomas, xanthelasma
LDL↑, normal TG & HDL.
|
|
Tubo-eruptive xanthomatous plaques (over the extremities, buttocks, and hands), Intertriginous xanthomas(極具指標性), CHD/aortic stenosis <20y/o, LDL>600mg/dL(heterozygous>300 mg/dL)
|
|
服用Statins+ ezetimibe,使LDL <130 mg/dL
有必要時LDL apheresis
|
|
Elevated LDL cholesterol, plasma β-sitosterol & campesterol
|
|
tendinous and tuberous xanthomas and premature CHD
|
|
Ezetimibe
|
|
Cholestanol
|
|
Cerebellar ataxia and dementia, tendinous xanthoma
|
|
Defects in the sterol 27-hydoxylase gene
|
|
Oral chenodeoxycholate 250 mg TID
|
|
Combined hyperlipidemia(Cholesterol+ TG) & marked HDL deficiency, monoclonal gammopathies, multiple myeloma
|
|
Cholesterol+TG= intestinal and liver remnant lipoprotein particles (dysbetalipoproteinemia)
|
|
Dietary modification, statins, fibrates, and niacin
|
|
Chylomicron remnants & VLDL remnants(IDL).
|
|
ApoE deficiency,或apoE2/2(正常為3/3),hepatic lipase deficiency
|
| |
|
Adult with xanthoma striatum palmare(characteristic) ,
Tubo-eruptive xanthomas on their elbows, hands, and even ears
Premature CHD, gout, and diabetes
|
|
↑non HDL cholesterol (total cholesterol—HDL cholesterol>200 mg/dL) and ↑remnant lipoprotein cholesterol (>100 mg/dL)
HDL正常,LDL降低
|
| |
|
都正常
|
|
apoA-I
|
|
Corneal opacification, premature CHD in their 30s. tubo-eruptive xanthomas, palmar and planar xanthomas
|
|
HDL cholesterol <10 mg/dL
|
|
optimizing all CHD risk factors (LDL <70 mg/dL, TG <150 mg/dL, no smoking, BP <130 mmHg, and HbA1c <7.0%),
|
|
monoclonal gammopathies, multiple myeloma, lymphoma and various forms of leukemia
|
|
Igs bind lipoprotein,延遲chylomicron remnants or VLDL remnants之清除(兩者會高)。
|
|
Tubo-eruptive, planar, and palmar xanthomas(同combined hyperlipidemia or dysbetalipoproteinemia)
|
|
治療underlying disorder, fenofibrate
|
|
Prolonged obstruction of the biliary tree (primary biliary cirrhosis and secondary biliary obstruction.)
|
|
↑ unesterified cholesterol.
|
|
Plane xanthomas (plaques on hands, feet, and trunk), xanthelasma, and tuberous xanthomas.
Jaundice, pruritus, and hyperpigmentation of the skin
|
|
解決obstruction. liver transplantation for stage 4 disease.
|
|
Yellow macules, soft papules, or plaques on the upper eyelids (xanthelasma palpebrarum), the wrists and palms (xanthoma striatum palmare), and in intertriginous area.
|
|
Eyelids, elevated LDL cholesterol 或完全健康的人
|
|
Ablative laser therapy(最佳), surgical excision, , trichloroacetic acid, cryotherapy
|
|
Multiple, reddish-yellow papules at extensor surface of extremities & buttocks(Appear suddenly)
|
|
Chylomicron and TG (fasting level >1,000 mg/dL, chylomicrons+), 嚴重會pancreatitis
|
|
Severe Hypertriglyceridemia(typeI: Familial chylomicronemia; typeV: Mixed hyperlipidemia), obesity, alcohol abuse, diabetes (type 2), and drugs
|
|
Lipoprotein lipase deficiency or apoC2 deficiency
|
|
Eruptivee xanthoma, Lipemia retinalis (milky plasma which can be visualized in retinal veins)
很少coronary atherosclerosis.
|
|
LDL <50 mg/dL
↑chylomicrons and VLDL,導致lipoprotein lipase活性很低
|
|
dietary modification.
|
|
Retinoids, estrogen, and protease inhibitors.
|
|
限 fat and sugars, weight loss,control diabetes, fibrates & fish oil.
|
Xanthomas in Children | |
|
homozygous FH, phytosterolemia/sitosterolemia, CTX, and Alagille syndrome
|
|
an inherited syndrome of biliary hypoplasia
|
|
A characteristic facies (a prominent forehead, hypertelorism, pointed chin, and nasal dystrophy), Cirrhosis,
|
|
cholesterol
|
|
liver transplantation
|
Verruciform Xanthoma(VX) | |
|
oral cavity
|
|
foamy histiocytes within elongated dermal papillae
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD)
|
|
Epidermolysis bullosa
|
Laboratory of xanthomas
| |
|
urine protein, serum creatinine(排除nephrotic syn.) and a hepatic panel(排除肝炎TG↑ & 膽道阻塞: LDL&Alp↑), fasting glucose(排除DM), thyroid function tests(排除hypothyroidism), a fasting lipid profile, lipoprotein(a), apoE genotyping, β-sitosterol, campesterol, and cholestanol.
|
|
fasts overnight
|
|
gas chromatography
|
|
LDL cholesterol (>160 mg/dL) or triglycerides (>150 mg/dL), or decreased levels of HDL cholesterol (<40 mg/dL)
|
|
↑TG, ↓HDL
|
|
↑LDL
|
|
↑TG, ↑HDL
|
Hyperlipidemias的治療
| |
|
↑ physical activity /weight control( preventing diabetes, ↓triglycerides, and ↑HDL)
Dietary management: ↓saturated fat/trans fats, ↓ cholesterol to <200 mg/day, vegetable oils, fish intake.
|
|
↓LDL: Statins > ezetimibe>resins.
↓TG: Fibrates(fenofibrate)> fish oil>niacin therapy.
↑HDL: Niacin
|
| |
|
dyspepsia, headaches, muscle or joint aches, liver transaminitis,severe myopathy leading to rhabdomyolysis.
|
| |
|
PPAR-αagonists
|
|
dyspepsia, gallstones(cholesterol secretion into bile)
會增強warfarin and certain hypoglycemic作用
|
|
Niaspan: extended release product (less flushing 2 g/day taken at bedtime)
|
| |
|
liver disease, gastric ulcer.
|
|
NPC1L1 inhibitor
Cholesterol and plant sterols經由 Niemann-Pick C-like protein 1 (NPC1L1) transporter吸收入腸
|
|
對statins無效者
|
|
↓LDL&CRP
|
| |
|
bind bile acids in intestine→↑conversion of liver cholesterol to bile acids/↑LDL receptors in liver→↓LDL
|
| |
|
eicosapentanoic acid (EPA) :消炎↓ immune response(↓IL-1, 6 and TNF-α), ↓ helper T cells & delayed hypersensitivity response
decohexanoic acid (DHA): 降血脂↓ TG, ↑HDL
|
|
↓dementia and Alzheimer disease
↓CHD, death from MI
|
此外,這幾個表也請注意一下。
Table 135-1 Clinical Presentations of Xanthomas
Type of Xanthoma
|
Genetic Disorders
|
Secondary Disorders
|
Eruptive
|
Familial lipoprotein lipase deficiency
|
Obesity
|
ApoC-II deficiency
|
Cholestasis
| |
ApoA-I and apoA-I/C-III deficiency
|
Diabetes
| |
Familial hypertriglyceridemia
|
Medications: retinoids, estrogen therapy, protease inhibitors
| |
Familial hypertriglyceridemia with chylomicronemia
| ||
Tuberous
|
Familial hypercholesterolemia
|
Monoclonal gammopathies
|
Familial dysbetalipoproteinemia
|
Multiple myeloma
| |
Phytosterolemia
|
Leukemia
| |
Tendinous
|
Familial hypercholesterolemia
| |
Familial defective apoB
| ||
Familial dysbetalipoproteinemia
| ||
Phytosterolemia
| ||
Cerebrotendinous xanthomatosis
| ||
Planar
| ||
Palmar
|
Familial dysbetalipoproteinemia
| |
Homozygous apoA-I deficiency
| ||
Intertriginous
|
Familial homozygous hypercholesterolemia
|
Cholestasis
|
Diffuse
|
Monoclonal gammopathies, cholestasis
| |
Familial hypercholesterolemia
| ||
Xanthelasma
|
Familial dysbetalipoproteinemia
|
Monoclonal gammopathies
|
Other
| ||
Corneal arcus
|
Familial hypercholesterolemia
| |
Tonsillar
|
Tangier disease
|
Table 135-2 Frederickson Classification of Familial Hyperlipidemias (Only Occasionally Used)
Frederickson Classification
|
Condition
|
Defect
|
Lipoprotein Increase
|
Type of Xanthoma
|
Type I
|
Familial chylomicronemia
|
Decreased lipoprotein lipase or altered apoC-II
|
Chylomicrons (and VLDL)
|
Eruptive xanthomata
|
Type IIa
|
Familial hypercholesterolemia
Heterozygous
Homozygous
|
LDL receptor or apoB deficiency
|
LDL
|
Tendon, tuberous, plane xanthomas (xanthelasma and intertriginous) 15% with xanthoma by second decade
Xanthomata by age 6 years
|
Type IIba
|
Familial combined hypercholesterolemia
|
Decreased LDL receptor and increased apoB
|
LDL and VLDL
|
Usually absent, but can have xanthomas as in type IIa
|
Type III
|
Familial dysbetalipoproteinemia
|
Defective apoE-2 synthesis
|
IDL
|
Palmar, tuberous, tubo-eruptive xanthoma, xanthelasma
|
Type IVb
|
Familial hypertriglyceridemia (pure)
|
Increased VLDL production and decreased elimination
|
VLDL
|
Rare eruptive xanthomas
|
Type V
|
Mixed hyperlipidemia
|
Increased VLDL production and decreased LPL
|
VLDL and chylomicrons
|
Eruptive xanthomas
|
Most familial hyperlipidemias associated with xanthomas are rare.
Box 135-1 Differential Diagnosis of Xanthomas
|